CN105412870A - Traditional Chinese medicine composition for treating enteritis and preparation method thereof - Google Patents

Traditional Chinese medicine composition for treating enteritis and preparation method thereof Download PDF

Info

Publication number
CN105412870A
CN105412870A CN201510899500.8A CN201510899500A CN105412870A CN 105412870 A CN105412870 A CN 105412870A CN 201510899500 A CN201510899500 A CN 201510899500A CN 105412870 A CN105412870 A CN 105412870A
Authority
CN
China
Prior art keywords
radix
parts
fructus
chinese medicine
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510899500.8A
Other languages
Chinese (zh)
Inventor
郜佩环
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhengzhou Renhong Pharmaceutical Technology Co Ltd
Original Assignee
Zhengzhou Renhong Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhengzhou Renhong Pharmaceutical Technology Co Ltd filed Critical Zhengzhou Renhong Pharmaceutical Technology Co Ltd
Priority to CN201510899500.8A priority Critical patent/CN105412870A/en
Publication of CN105412870A publication Critical patent/CN105412870A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9062—Alpinia, e.g. red ginger or galangal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating enteritis and a preparation method thereof. The traditional Chinese medicine composition is prepared from, by weight, 15-22 parts of radix codonopsis, 10-14 parts of rhizoma atractylodis macrocephalae, 5-9 parts of radix angelicae pubescentis, 6-12 parts of baked ginger, 16-22 parts of licorice roots, 9-14 parts of fructus alpiniae oxyphyllae, 4-9 parts of peach kernels, 12-18 parts of fructus mume, 6-11 parts of herba rabdosiae, 3-6 parts of radix platycodonis, 14-19 parts of fructus kochiae and 4-8 parts of swamp mahogany leaves. All the materials are cleaned, cut and dried, radix codonopsis, rhizoma atractylodis macrocephalae and the like are decocted for three times with water, concentration, alcohol precipitation and drying are conducted, and an extract A is prepared; ethyl alcohol is added to herba rabdosiae, radix platycodonis and the like, reflux and drying are conducted, and an extract B is obtained; the extract A and the extract B are merged, smashed and mixed, and the traditional Chinese medicine composition is obtained. The traditional Chinese medicine composition for treating the enteritis can rapidly eliminate the symptoms such as diarrhea, bloody purulent stool and abdominal pain of patients with ulcerative enteritis and can significantly improve intestinal mucosa pathological changes, eliminate inflammatory mediator and facilitate ulcer healing, and therefore a good therapeutical effect is achieved. The total effective rate is 96 percent, and adverse effects and toxic and side effects are not found.

Description

A kind of Chinese medicine composition for the treatment of enteritis and preparation method thereof
Technical field
The present invention relates to, specifically a kind of Chinese medicine composition for the treatment of enteritis and preparation method thereof.
Background technology
Enteritis be a kind of agnogenic be the chronic inflammation disease of feature with large intestine (mainly rectum and colon) mucosa and tela submucosa.Ulcerative enteritis is a kind of cause of disease coton and rectal chronic nonspecific inflammation disease still not fully aware of, and pathological changes is confined to colorectal mucosa and Submucosa.Pathological changes multidigit, in sigmoid colon and rectum, also may extend to descending colon, even whole colon.The course of disease is very long, normal recurrent exerbation.Primary disease sees any age, but 20 ~ 30 years old the most common.The cause of disease of ulcerative enteritis is still failed to understand so far.
Treatment traditional is at present take medicine and injection substantially, and the whole colon treatment of excision.The similar Salicylates of the many employings of present Drug therapy and glucocorticoid etc., such as: medicine and the preparations such as sulfasalazine, azathioprine, ciclosporin.And in these medicines, very large to the side effect of liver as sulfasalazine, and can not share or prolonged application with antibiotic.Operative treatment, excises whole colon exactly, but due to operation complication more, have a strong impact on the quality of life of postoperative patient.
Summary of the invention
The object of the present invention is to provide Chinese medicine composition of a kind for the treatment of enteritis of effective, instant effect and preparation method thereof, to solve the problem proposed in above-mentioned background technology.
For achieving the above object, the invention provides following technical scheme:
A kind of Chinese medicine composition for the treatment of enteritis, be made up of Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Pubescentis, Rhizoma Zingiberis Preparatum, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae, Semen Persicae, Fructus Mume, Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae, each raw material according to weight portion is: Radix Codonopsis 15-22 part, Rhizoma Atractylodis Macrocephalae 10-14 part, Radix Angelicae Pubescentis 5-9 part, Rhizoma Zingiberis Preparatum 6-12 part, Radix Glycyrrhizae 16-22 part, Fructus Alpiniae Oxyphyllae 9-14 part, Semen Persicae 4-9 part, Fructus Mume 12-18 part, Rabdosia rubescens 6-11 part, Radix Platycodonis 3-6 part, Fructus Kochiae 14-19 part, Folium Eucalypti Robustae 4-8 part.
As the further scheme of the present invention: the Chinese medicine composition of described treatment enteritis, be made up of Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Pubescentis, Rhizoma Zingiberis Preparatum, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae, Semen Persicae, Fructus Mume, Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae, each raw material according to weight portion is: Radix Codonopsis 17-20 part, Rhizoma Atractylodis Macrocephalae 11-13 part, Radix Angelicae Pubescentis 6-8 part, Rhizoma Zingiberis Preparatum 8-10 part, Radix Glycyrrhizae 18-20 part, Fructus Alpiniae Oxyphyllae 10-13 part, Semen Persicae 6-7 part, Fructus Mume 14-16 part, Rabdosia rubescens 8-9 part, Radix Platycodonis 4-5 part, Fructus Kochiae 16-17 part, Folium Eucalypti Robustae 5-7 part.
As the further scheme of the present invention: the Chinese medicine composition of described treatment enteritis, be made up of Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Pubescentis, Rhizoma Zingiberis Preparatum, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae, Semen Persicae, Fructus Mume, Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae, each raw material according to weight portion is: Radix Codonopsis 18 parts, the Rhizoma Atractylodis Macrocephalae 12 parts, Radix Angelicae Pubescentis 7 parts, Rhizoma Zingiberis Preparatum 9 parts, 19 parts, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae 12 parts, 6 parts, Semen Persicae, Fructus Mume 15 parts, Rabdosia rubescens 8 parts, Radix Platycodonis 4 parts, the Fructus Kochiae 16 parts, Folium Eucalypti Robustae 6 parts.
The preparation method of the Chinese medicine composition of described treatment enteritis, concrete steps comprise:
1) Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Pubescentis, Rhizoma Zingiberis Preparatum, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae, Semen Persicae, Fructus Mume, Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae are cleaned, cutting dry, take by weight, for subsequent use;
2) Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Pubescentis, Rhizoma Zingiberis Preparatum, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae, Semen Persicae, Fructus Mume are added all Chinese medicine composition gross weight 7-8 soak by water doubly three times, each is 1-1.5h, filter and merging filtrate, be condensed into the extractum that proportion is 1.0, add ethanol and carry out precipitate with ethanol, reclaim ethanol and concentrate, dry at 60-65 DEG C, obtained extractum A;
3) Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae are added alcohol reflux 2-3h, ethanol consumption be Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae gross weight 7-8 doubly, obtain extracting solution and reclaim ethanol, dry at 60-65 DEG C, obtain extractum B;
4) merge extractum A and extractum B, be ground into fine powder and mix homogeneously, be i.e. obtained Chinese medicine composition.
As the further scheme of the present invention: add pharmaceutically acceptable adjuvant in step 4) and prepare pharmaceutical preparation, make pill or other acceptable granule, drop pill, tablet, capsule, soft capsule, suspensoid, oral liquid etc. clinically.
The mechanism of action of Raw of the present invention: Radix Codonopsis the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity.Radix Codonopsis Herb water extract 1g/kg, to mouse stomach, obviously can reduce the irritability caused by electricity irritation mice and battle array spasm, and phenobarbital can be made to extend the mouse anesthesia effect enhancing under anoxia condition, life span.The excitation that extract energy antagonism amfetamine causes, shows obvious analgesis active.Rhizoma Atractylodis Macrocephalae kidney-replenishing, bone and muscle strengthening, wind-damp dispelling.Promote propagation and the differentiation of hematopoietic stem cell.Radix Angelicae Pubescentis eliminating blood stasis and inducing menstruation, easing joint movement, inducing diuresis for treating stranguria syndrome.Rhizoma Zingiberis Preparatum invigorating the liver and kidney, reuniting the fractured tendons and bones, blood circulation regulating.Control aching pain in waist and back, the foot and knee being feeble, vaginal bleeding during pregnancy, metrorrhagia, leukorrhagia, seminal emission, traumatic injury, incised wound, anal fistula, carbuncle skin ulcer swells.Radix Glycyrrhizae invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, the agent of coordinating the actions of various ingredients in a prescription Radix Glycyrrhizae has the function of antiinflammatory and antiallergic action.Relieving cough, eliminates the phlegm, treatment pharyngalgia laryngitis; Radix Glycyrrhizae or enoxolone have the effect of desoxycortone class; Glycyrrhiza preparation can promote stomach mucus to be formed and secretion, extends the epithelial cell life-span, has anti-inflammatory activity; The flavone of Radix Glycyrrhizae has antiinflammatory, spasmolytic and antiacid effect.The useful taste of Fructus Alpiniae Oxyphyllae, reason vigour, the function of the sliding drop of the kidney invigorating void.Control having loose bowels caused by taste (or kidney) deficiency and coldness, stomachache, vomiting, inappetence, salivation increases, the enuresis, the diseases such as frequent micturition.Semen Persicae blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation, relieving cough and asthma.Fructus Mume is astringed the lung, astringing intestine to stop diarrhea, promotes the production of body fluid, relieving colic caused by ascaris.Rabdosia rubescens heat-clearing and toxic substances removing, promoting blood circulation and stopping pain.Radix Platycodonis lung qi dispersing, sore-throat relieving, eliminates the phlegm, evacuation of pus.For cough with copious phlegm, uncomfortable in chest not smooth, pharyngalgia, hoarseness, lung abscess vomiting pus, skin infection difficulty in discharging of pus.Fructus Kochiae clearing away heat-damp and promoting diuresis, dispelling wind for relieving itching.Folium Eucalypti Robustae has heat-clearing and toxic substances removing, resistance to compression, antibacterial effect.
Compared with prior art, the invention has the beneficial effects as follows:
Take the present invention and comparatively fast can eliminate the clinical symptoms such as ulcerative enteritis patient diarrhoea, bloody purulent stool, stomachache, significantly can improve intestinal mucosa pathological change, diminish inflammation medium, promotes ulcer healing, thus reach good therapeutical effect; Total effective rate is 96%; Treatment group cure rate and total effective rate, all apparently higher than matched group, have pole significant difference (P<0.05).Safety detection display, after Chinese medicinal composition capsules treatment group patient treatment of the present invention, hepatic and renal function, electrocardiogram, x-ray rabat, hematuria routine etc. check change all without exception, do not find untoward reaction and toxic and side effects, point out this medicine to be one Chinese medicine composition compound pharmaceutical safely and effectively.
Detailed description of the invention
Below in conjunction with the embodiment of the present invention, be clearly and completely described the technical scheme in the embodiment of the present invention, obviously, described embodiment is only the present invention's part embodiment, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making the every other embodiment obtained under creative work prerequisite, belong to the scope of protection of the invention.
Embodiment 1
In the embodiment of the present invention, take raw material: Radix Codonopsis 15g, Rhizoma Atractylodis Macrocephalae 10g, Radix Angelicae Pubescentis 5g, Rhizoma Zingiberis Preparatum 6g, Radix Glycyrrhizae 16g, Fructus Alpiniae Oxyphyllae 9g, Semen Persicae 4g, Fructus Mume 12g, Rabdosia rubescens 6g, Radix Platycodonis 3g, Fructus Kochiae 14g, Folium Eucalypti Robustae 4g.
The concrete steps of preparation comprise:
1) Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Pubescentis, Rhizoma Zingiberis Preparatum, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae, Semen Persicae, Fructus Mume, Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae are cleaned, cutting dry, take by above-mentioned weight, for subsequent use;
2) Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Pubescentis, Rhizoma Zingiberis Preparatum, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae, Semen Persicae, Fructus Mume are added all Chinese medicine composition gross weight 7-8 soak by water doubly three times, each is 1-1.5h, filter and merging filtrate, be condensed into the extractum that proportion is 1.0, add ethanol and carry out precipitate with ethanol, reclaim ethanol and concentrate, dry at 60-65 DEG C, obtained extractum A;
3) Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae are added alcohol reflux 2-3h, ethanol consumption be Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae gross weight 7-8 doubly, obtain extracting solution and reclaim ethanol, dry at 60-65 DEG C, obtain extractum B;
4) merge extractum A and extractum B, be ground into fine powder and mix homogeneously, add adjuvant, obtained granule, tabletting, obtains tablet.
Embodiment 2
In the embodiment of the present invention, take raw material: Radix Codonopsis 22g, Rhizoma Atractylodis Macrocephalae 14g, Radix Angelicae Pubescentis 9g, Rhizoma Zingiberis Preparatum 12g, Radix Glycyrrhizae 22g, Fructus Alpiniae Oxyphyllae 14g, Semen Persicae 9g, Fructus Mume 18g, Rabdosia rubescens 11g, Radix Platycodonis 6g, Fructus Kochiae 19g, Folium Eucalypti Robustae 8g.Preparation process is consistent with embodiment 1.
Embodiment 3
In the embodiment of the present invention, take raw material: Radix Codonopsis 17g, Rhizoma Atractylodis Macrocephalae 11g, Radix Angelicae Pubescentis 6g, Rhizoma Zingiberis Preparatum 8g, Radix Glycyrrhizae 18g, Fructus Alpiniae Oxyphyllae 10g, Semen Persicae 6g, Fructus Mume 14g, Rabdosia rubescens 8g, Radix Platycodonis 4g, Fructus Kochiae 16g, Folium Eucalypti Robustae 5g.Preparation process is consistent with embodiment 1.
Embodiment 4
In the embodiment of the present invention, take raw material: Radix Codonopsis 20g, Rhizoma Atractylodis Macrocephalae 13g, Radix Angelicae Pubescentis 8g, Rhizoma Zingiberis Preparatum 10g, Radix Glycyrrhizae 20g, Fructus Alpiniae Oxyphyllae 13g, Semen Persicae 7g, Fructus Mume 16g, Rabdosia rubescens 9g, Radix Platycodonis 5g, Fructus Kochiae 17g, Folium Eucalypti Robustae 7g.Preparation process is consistent with embodiment 1.Incapsulate unlike by granule, obtain capsule.
Embodiment 5
In the embodiment of the present invention, take raw material: Radix Codonopsis 18g, Rhizoma Atractylodis Macrocephalae 12g, Radix Angelicae Pubescentis 7g, Rhizoma Zingiberis Preparatum 9g, Radix Glycyrrhizae 19g, Fructus Alpiniae Oxyphyllae 12g, Semen Persicae 6g, Fructus Mume 15g, Rabdosia rubescens 8g, Radix Platycodonis 4g, Fructus Kochiae 16g, Folium Eucalypti Robustae 6g.Preparation process is consistent with embodiment 1.Incapsulate unlike by granule, obtain capsule.
Embodiment 6
In the embodiment of the present invention, take raw material: Radix Codonopsis 15g, Rhizoma Atractylodis Macrocephalae 14g, Radix Angelicae Pubescentis 6g, Rhizoma Zingiberis Preparatum 7g, Radix Glycyrrhizae 18g, Fructus Alpiniae Oxyphyllae 10g, Semen Persicae 5g, Fructus Mume 16g, Rabdosia rubescens 10g, Radix Platycodonis 5g, Fructus Kochiae 18g, Folium Eucalypti Robustae 4g.Preparation process is consistent with embodiment 1.Incapsulate unlike by granule, obtain capsule.
Embodiment 7
In the embodiment of the present invention, take raw material: Radix Codonopsis 22g, Rhizoma Atractylodis Macrocephalae 10g, Radix Angelicae Pubescentis 8g, Rhizoma Zingiberis Preparatum 11g, Radix Glycyrrhizae 20g, Fructus Alpiniae Oxyphyllae 12g, Semen Persicae 6g, Fructus Mume 13g, Rabdosia rubescens 7g, Radix Platycodonis 5g, Fructus Kochiae 14g, Folium Eucalypti Robustae 7g.Preparation process is consistent with embodiment 1.Incapsulate unlike by granule, obtain capsule.
Embodiment 8
In the embodiment of the present invention, take raw material: Radix Codonopsis 17g, Rhizoma Atractylodis Macrocephalae 11g, Radix Angelicae Pubescentis 9g, Rhizoma Zingiberis Preparatum 6g, Radix Glycyrrhizae 21g, Fructus Alpiniae Oxyphyllae 11g, Semen Persicae 8g, Fructus Mume 17g, Rabdosia rubescens 11g, Radix Platycodonis 3g, Fructus Kochiae 15g, Folium Eucalypti Robustae 5g.Preparation process is consistent with embodiment 1.
Embodiment 9
In the embodiment of the present invention, take raw material: Radix Codonopsis 21g, Rhizoma Atractylodis Macrocephalae 12g, Radix Angelicae Pubescentis 8g, Rhizoma Zingiberis Preparatum 10g, Radix Glycyrrhizae 22g, Fructus Alpiniae Oxyphyllae 9g, Semen Persicae 7g, Fructus Mume 18g, Rabdosia rubescens 7g, Radix Platycodonis 3g, Fructus Kochiae 16g, Folium Eucalypti Robustae 4g.Preparation process is consistent with embodiment 1.
Embodiment 10
In the embodiment of the present invention, take raw material: Radix Codonopsis 16g, Rhizoma Atractylodis Macrocephalae 13g, Radix Angelicae Pubescentis 6g, Rhizoma Zingiberis Preparatum 10g, Radix Glycyrrhizae 16g, Fructus Alpiniae Oxyphyllae 13g, Semen Persicae 6g, Fructus Mume 14g, Rabdosia rubescens 6g, Radix Platycodonis 5g, Fructus Kochiae 19g, Folium Eucalypti Robustae 8g.Preparation process is consistent with embodiment 1.Incapsulate unlike by granule, obtain capsule.
Below scientific experimentation example further illustrates beneficial effect of the present invention when participating in the cintest.Wherein used outturn sample of the present invention is the capsule product of following embodiment 5 preparation.During human trial, usage and dosage of the present invention is: oral, each 2, every day 3 times.
Test example 1: acute toxicity test in mice
The acute toxicity test in mice of Chinese medicine composition pharmacology teaching and research room of Anhui University of Chinese Medecine to this product is studied, result shows: Kunming Strains of Mouse 40, per os three times on the one gastric infusions, 8 hours, interval, dosage adds up as 28.8g dry powder/kg(is equivalent to 187 times of quantity) time, Continuous Observation one week, mice, without death, does not find any untoward reaction.According to " Chinese medicine composition new drug research guide " (94-0198) chapter 2 the acute toxicity tests evaluation criterion, this product oral administration acute toxicity is substantially nontoxic.
Test example 2: Pharmacodynamic test of active extract.
Chinese medicine composition pharmacology teaching and research room of Anhui University of Chinese Medecine has carried out experimentation to the drug effect of this product, and result shows the Rats with Spleen-deficiency ulcerative enteritis pathology damage that Chinese medicine composition of the present invention (0.5g/kg, 1.0g/kg, 2.0g/kg) obviously can alleviate acetic acid and causes; Chinese medicine composition of the present invention (0.7g/kg, 1.4g/kg, 2.8g/kg) xylol induced mice ear swelling has obvious inhibitory action; Obvious analgesic activity is had to 0.6% acetic acid induced mice pain; Immunologic hypofunction Phagocytosis By The Peritoneal Macrophages In Mice can be improved.
Test example 3: rat chronic toxicity test.
Chinese medicine composition pharmacology teaching and research room of the college of traditional Chinese medicine of Hebei Medical University has carried out rat chronic toxicity test to this product.Result shows, oral suspension administration, dosage 2.0g dry powder/kg, 4.0g dry powder/kg, 8.0g dry powder/kg(is equivalent to 14 times, 28 times, 56 times of clinical application), result shows, Chinese medicine composition of the present invention (2.0g/kg, 4.0g/kg, 8.0g/kg) all has no significant effect the general status body weight of rat, hematological indices, ten biochemical indicators and Main Organ Coefficients, each internal organs naked eyes and Microscopic observation, also without obvious pathological change.Show that this medicine reacts without overt toxicity, illustrate that the medication under this experiment condition of this product is basic security, pointing out this product to use under prescribed dose is possible safe and reliable.
Test example 4: clinical observation on the therapeutic effect.
4.1 physical data
Choose enteritis patient 100 example, age 20-65 year, man 55 example, female 45 example, all cases all meets diagnostic criteria that " curative effect determinate standard of chronic nonspecific ulcerative enteritis " that All-China Association of Traditional Chinese Medicine analogy can formulate for 1987 formulate, tcm diagnosis is retention of damp-heat in the interior, qi depression to blood stasis, asthenia of both the spleen and kidney, deficiency of YIN-blood person sign the case of Informed Consent Form.
4.2 experimental technique
100 patients are divided into treatment group and matched group respectively according to table of random number, treatment group 50 example, matched group 50 example, treatment group adopts the capsule of the embodiment of the present invention 5, and matched group adopts sulfasalazine.Treatment group takes Chinese medicinal composition capsules of the present invention, every dress 0.3g, oral, a 2-4 grain, 3 times on the one.Matched group takes sulfasalazine agent, every sheet 0.25g, each oral 1g, every day 3 times.Treatments period withdraws other drug, and two groups of equal continuous uses 20 days are 1 course for the treatment of, and 2 courses for the treatment of terminate rear check intestinal mirror, pathology and relevant observation index, statistics curative effect.
4.3 the standard of curative effect evaluation
Cure: clinical symptom disappearance, intestinal mirror etc. check that intestinal mucosal lesion recovers normal.
Take a turn for the better: clinical symptom relief, intestinal mirror etc. check that intestinal mucosal lesion improves, and stool routine examination has a small amount of red white corpuscle.
Invalid: before and after treatment, clinical symptoms and intestinal mirror etc. check without improving or being not improved.
4.4 statistical method
Adopt SPSS13.0 statistical software to analyze, enumeration data adopts X 2 test, is that difference has statistical significance with P<0.05.
4.5 result of the test
Treatment group patient total effective rate reaches 96%, and matched group patient total effective rate is 72%, and treatment group total effective rate is apparently higher than matched group total effective rate, and difference has statistical significance (P ﹤ 0.05).In table 1.
A table 1 liang group patient total effective rate compares
Group Case load (n) Cure Take a turn for the better Invalid Total effective rate (%)
Treatment group 50 40 8 2 96
Matched group 50 30 6 14 72
To those skilled in the art, obviously the invention is not restricted to the details of above-mentioned one exemplary embodiment, and when not deviating from spirit of the present invention or basic feature, the present invention can be realized in other specific forms.Therefore, no matter from which point, all should embodiment be regarded as exemplary, and be nonrestrictive, scope of the present invention is limited by claims instead of above-mentioned explanation, and all changes be therefore intended in the implication of the equivalency by dropping on claim and scope are included in the present invention.
In addition, be to be understood that, although this description is described according to embodiment, but not each embodiment only comprises an independently technical scheme, this narrating mode of description is only for clarity sake, those skilled in the art should by description integrally, and the technical scheme in each embodiment also through appropriately combined, can form other embodiments that it will be appreciated by those skilled in the art that.

Claims (5)

1. treat the Chinese medicine composition of enteritis for one kind, it is characterized in that, be made up of Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Pubescentis, Rhizoma Zingiberis Preparatum, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae, Semen Persicae, Fructus Mume, Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae, each raw material according to weight portion is: Radix Codonopsis 15-22 part, Rhizoma Atractylodis Macrocephalae 10-14 part, Radix Angelicae Pubescentis 5-9 part, Rhizoma Zingiberis Preparatum 6-12 part, Radix Glycyrrhizae 16-22 part, Fructus Alpiniae Oxyphyllae 9-14 part, Semen Persicae 4-9 part, Fructus Mume 12-18 part, Rabdosia rubescens 6-11 part, Radix Platycodonis 3-6 part, Fructus Kochiae 14-19 part, Folium Eucalypti Robustae 4-8 part.
2. the Chinese medicine composition for the treatment of enteritis according to claim 1, it is characterized in that, be made up of Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Pubescentis, Rhizoma Zingiberis Preparatum, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae, Semen Persicae, Fructus Mume, Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae, each raw material according to weight portion is: Radix Codonopsis 17-20 part, Rhizoma Atractylodis Macrocephalae 11-13 part, Radix Angelicae Pubescentis 6-8 part, Rhizoma Zingiberis Preparatum 8-10 part, Radix Glycyrrhizae 18-20 part, Fructus Alpiniae Oxyphyllae 10-13 part, Semen Persicae 6-7 part, Fructus Mume 14-16 part, Rabdosia rubescens 8-9 part, Radix Platycodonis 4-5 part, Fructus Kochiae 16-17 part, Folium Eucalypti Robustae 5-7 part.
3. the Chinese medicine composition for the treatment of enteritis according to claim 2, it is characterized in that, be made up of Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Pubescentis, Rhizoma Zingiberis Preparatum, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae, Semen Persicae, Fructus Mume, Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae, each raw material according to weight portion is: Radix Codonopsis 18 parts, the Rhizoma Atractylodis Macrocephalae 12 parts, Radix Angelicae Pubescentis 7 parts, Rhizoma Zingiberis Preparatum 9 parts, 19 parts, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae 12 parts, 6 parts, Semen Persicae, Fructus Mume 15 parts, Rabdosia rubescens 8 parts, Radix Platycodonis 4 parts, the Fructus Kochiae 16 parts, Folium Eucalypti Robustae 6 parts.
4. a preparation method for the Chinese medicine composition of the treatment enteritis as described in as arbitrary in claim 1-3, it is characterized in that, concrete steps comprise:
1) Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Pubescentis, Rhizoma Zingiberis Preparatum, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae, Semen Persicae, Fructus Mume, Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae are cleaned, cutting dry, take by weight, for subsequent use;
2) Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Pubescentis, Rhizoma Zingiberis Preparatum, Radix Glycyrrhizae, Fructus Alpiniae Oxyphyllae, Semen Persicae, Fructus Mume are added all Chinese medicine composition gross weight 7-8 soak by water doubly three times, each is 1-1.5h, filter and merging filtrate, be condensed into the extractum that proportion is 1.0, add ethanol and carry out precipitate with ethanol, reclaim ethanol and concentrate, dry at 60-65 DEG C, obtained extractum A;
3) Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae are added alcohol reflux 2-3h, ethanol consumption be Rabdosia rubescens, Radix Platycodonis, the Fructus Kochiae, Folium Eucalypti Robustae gross weight 7-8 doubly, obtain extracting solution and reclaim ethanol, dry at 60-65 DEG C, obtain extractum B;
4) merge extractum A and extractum B, be ground into fine powder and mix homogeneously, be i.e. obtained Chinese medicine composition.
5. the preparation method of the Chinese medicine composition for the treatment of enteritis according to claim 4, is characterized in that, adds pharmaceutically acceptable adjuvant and prepare pharmaceutical preparation in step 4).
CN201510899500.8A 2015-12-09 2015-12-09 Traditional Chinese medicine composition for treating enteritis and preparation method thereof Pending CN105412870A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510899500.8A CN105412870A (en) 2015-12-09 2015-12-09 Traditional Chinese medicine composition for treating enteritis and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510899500.8A CN105412870A (en) 2015-12-09 2015-12-09 Traditional Chinese medicine composition for treating enteritis and preparation method thereof

Publications (1)

Publication Number Publication Date
CN105412870A true CN105412870A (en) 2016-03-23

Family

ID=55491708

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510899500.8A Pending CN105412870A (en) 2015-12-09 2015-12-09 Traditional Chinese medicine composition for treating enteritis and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105412870A (en)

Similar Documents

Publication Publication Date Title
CN102008650B (en) Compound traditional Chinese medicine preparation for treating tumors and preparation method thereof
CN101537159B (en) Traditional Chinese medicine composition and preparation method and application thereof
CN102293985B (en) Traditional Chinese medicine composition used for treating coronary heart disease and preparation method thereof
CN104706953A (en) Traditional Chinese medicine preparation for treating chronic cervicitis
CN104491459A (en) Traditional Chinese medicine composition for treating tumors
CN115025203A (en) Traditional Chinese medicine composition for preparing intestinal tract before colonoscopy
CN105381364A (en) Traditional Chinese medicine for treating chronic colitis and preparation method thereof
CN101708292B (en) Chinese medicament for treating rheumatic and rheumatoid diseases
CN100431578C (en) Preparation of Chinese traditional medicine for treating hyperplasia of prostate
CN104645191A (en) Traditional Chinese medicine composition for treating chronic ulcerative colitis and preparation method thereof
CN105770691A (en) Medicinal preparation for treating cervical cancer and application thereof
CN103405708B (en) Drug for treating chronic enteritis and preparation method thereof
CN103386101B (en) Traditional Chinese medicine preparation for nonspecific cystitis treatment and preparation method thereof
CN105412870A (en) Traditional Chinese medicine composition for treating enteritis and preparation method thereof
CN104800675A (en) Medicament for treating active ulcerative colitis
CN105381363A (en) Traditional Chinese medicine for treating colitis and preparation method thereof
CN104383349A (en) Drug for postoperative recovery of bladder cancer and preparation method of drug for postoperative recovery of bladder cancer
CN110478416A (en) The composition and its preparation method and application for treating rheumatic rheumatoid arthritis
CN105265786A (en) Compound feed for cows and preparation method thereof
CN100443093C (en) AIDS treating medicine
CN107007697A (en) One kind treats pelvic infecton or prostatitic Chinese medicine composition and its preparation
CN101164578B (en) Traditional Chinese medicine composition for treating hemorrhoid, and method for preparing same
CN105434808A (en) Traditional Chinese medicine composition for treating hemorrhoids and preparation method thereof
CN109419844B (en) Tibetan medicine composition for treating osteoarthritis pain
CN105521370A (en) Pharmaceutical preparation for treating colon cancer and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160323